Please login to the form below

Not currently logged in
Email:
Password:

Onyx Health wins OLM Diagnostics account

Will develop a marketing strategy for the UK-based firm

Onyx Health

Marketing communications agency, Onyx Health has been appointed by Newcastle upon Tyne, UK-based OLM Diagnostics to develop and implement a marketing strategy to raise awareness of its diagnostic-led approach to fungal and bacterial testing.

Frazer Thompson, operations director and OLM Diagnostics, said: “Having met the team, I could immediately see the value in what Onyx Health offers.

“In a short timeframe, they’ve already developed impactful messages and branding that has resonated well with our customers.”

The anti-fungal resistance-focussed organisation has developed a range of fungal and bacterial diagnostic tests into current treatment pathways to reduce to the rate of drug resistant infections.

Karen Winterhalter, Onxy’s health director, said: “The North East has gained international recognition for healthcare innovation, and OLM Diagnostics is a great example of this.

“Our knowledge of the healthcare market enables us to develop and implement sales and marketing strategies to help companies navigate the complexities of global healthcare markets.”

Article by
Gemma Jones

28th June 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Health

Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in...

Latest intelligence

When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...